XERS
Xeris Biopharma Holdings Inc
15.52%
$1.16 - $1.34
Feb 7th 2023 - Mar 21st 2023
Mar, 17, 2023
Two other drugs, each growing revenue steadily.
Mar, 13, 2023
That said, I fully expect continuing script and r... See more
BABA
Alibaba Group Holding Ltd - ADR
-20.42%
$105.11 - $83.65
Feb 8th 2023 - Mar 22nd 2023
Mar, 18, 2023
Solid growth revenue guaranteed !
Mar, 15, 2023
company is actually doing spectacular and 190B+ in... See more
HKD
AMTD Digital Inc - ADR
-24.37%
$9.48 - $7.17
Feb 8th 2023 - Mar 22nd 2023
Mar, 20, 2023
$HKD: The Revenue has been growing by 138.30% on a... See more
Mar, 17, 2023
$HKD: The Revenue has been growing by 138.30% on a... See more
Mar, 17, 2023
Two other drugs, each growing revenue steadily.
Mar, 13, 2023
That said, I fully expect continuing script and revenue growth, upcoming cashflow breakeven and some nice juicy licensing deals to resolve that in the months ahead.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Feb, 24, 2023
There is so much good news here, growing revenue, a stable base, conservative management, and connections to big pharma.
Mar, 18, 2023
Solid growth revenue guaranteed !
Mar, 15, 2023
company is actually doing spectacular and 190B+ in revenues next year.
Mar, 14, 2023
On an annual basis, analysts expect healthy growth of 35% year-over-year.
Mar, 14, 2023
In 2023, we believe we have a clear path to reaccelerate our revenue growth, and we are now well positioned to make use of the opportunities that China’s economic recovery offers us,” said Robin Li, Co-founder and CEO of Baidu.
Mar, 7, 2023
$BABA shows a strong growth in Revenue.
Mar, 7, 2023
$BABA $BIDU Huge revenue growth !
Mar, 6, 2023
$BABA shows a strong growth in Revenue.
Mar, 6, 2023
$BABA shows a strong growth in Revenue.
Feb, 25, 2023
$BABA: The Revenue has been growing by 40.06% on average over the past 5 years.
Feb, 25, 2023
$BABA $BIDU $PLTR $SNAP $TDOC These are deep intrinsic value stocks with strong BS Revenue EBITDA Cash Flow Industry Leaders and Able Leadership !
Mar, 20, 2023
$HKD: The Revenue has been growing by 138.30% on average over the past 5 years.
Mar, 17, 2023
$HKD: The Revenue has been growing by 138.30% on average over the past 5 years.
Mar, 14, 2023
$HKD: The Revenue has been growing by 138.30% on average over the past 5 years.
Mar, 13, 2023
$HKD: The Revenue has been growing by 138.30% on average over the past 5 years.
Mar, 9, 2023
$HKD shows a strong growth in Revenue.
Mar, 9, 2023
$HKD: The Revenue has been growing by 138.30% on average over the past 5 years.
Mar, 8, 2023
So many avenues for revenue with HKD.
Mar, 2, 2023
$HKD: The Revenue has been growing by 138.30% on average over the past 5 years.
Feb, 23, 2023
$HKD it's pretty simple, no debt, crazy amount of cash, huge increase first six months revenue and way undervalued.
Feb, 23, 2023
No debt, ridiculous balance sheet and 98 percent profit margins + 130 Percent Revenue Growth.